CDK4/6 inhibitors prolong OS

被引：0
|
作者：
David Killock
机构：
[1] Nature Reviews Clinical Oncology,
来源：
Nature Reviews Clinical Oncology | 2019年 / 16卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：722 / 722
相关论文
共 50 条
  • [1] CDK4/6 inhibitors prolong OS
    Killock, David
    NATURE REVIEWS CLINICAL ONCOLOGY, 2019, 16 (12) : 722 - 722
  • [2] CDK4/6 inhibitors
    不详
    CHEMICAL & ENGINEERING NEWS, 2016, : 30 - 31
  • [3] CDK4/6 inhibitors: The Devil is in the Detail
    Magge, Tara
    Rajendran, Sneha
    Brufsky, Adam M.
    Foldi, Julia
    CURRENT ONCOLOGY REPORTS, 2024, 26 (06) : 665 - 678
  • [4] Development and strategies of CDK4/6 inhibitors
    Chen, Pingping
    Xu, Yinqiu
    Li, Xuanyi
    Yao, Hequan
    Lin, Kejiang
    FUTURE MEDICINAL CHEMISTRY, 2020, 12 (02) : 127 - 145
  • [5] Immunomodulatory effects of CDK4/6 inhibitors
    Zhang, Shumeng
    Xu, Qiaomai
    Sun, Wenjia
    Zhou, Jianya
    Zhou, Jianying
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2023, 1878 (04):
  • [6] CDK4/6 inhibitors in breast cancer
    Dukelow, Tim
    Kishan, Divya
    Khasraw, Mustafa
    Murphy, Conleth G.
    ANTI-CANCER DRUGS, 2015, 26 (08) : 797 - 806
  • [7] The Role of CDK4/6 Inhibitors in Breast Cancer
    Murphy, Conleth G.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2019, 20 (06)
  • [8] Recent Progress in CDK4/6 Inhibitors and PROTACs
    Wang, Hao
    Ba, Jianfei
    Kang, Yue
    Gong, Zeqiao
    Liang, Tingting
    Zhang, Yahong
    Qi, Jianguo
    Wang, Jianhong
    MOLECULES, 2023, 28 (24):
  • [9] Treating cancer with selective CDK4/6 inhibitors
    Ben O'Leary
    Richard S. Finn
    Nicholas C. Turner
    Nature Reviews Clinical Oncology, 2016, 13 : 417 - 430
  • [10] Update on CDK4/6 Inhibitors in Breast Cancer
    Tolaney, Sara M.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2024, 22 (06) : 298 - 300
12345